COVID-Aging: Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on Survival in Elderly Patients With COVID19: A Randomized, Multicenter, Double-Blind Study.
- Funded by Ministre des Solidarités et de la Santé (France)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Ministre des Solidarités et de la Santé (France)Principal Investigator
Frédéric BlancResearch Location
FranceLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Randomized Controlled Trial
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)Older adults (65 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified